New England Asset Management Inc Eli Lilly & CO Transaction History

New England Asset Management Inc

$604 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $271,523 - $320,090	-517 Reduced 10.98%	4,193 $2.44 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $2.89 Million - $3.99 Million	-6,650 Reduced 58.54%	4,710 $2.53 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $141,026 - $165,628	-454 Reduced 3.84%	11,360 $3.9 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $2.93 Million - $3.41 Million	-9,100 Reduced 43.51%	11,814 $4.32 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $6.89 Million - $7.86 Million	-23,250 Reduced 52.64%	20,914 $6.76 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $209,047 - $245,452	750 Added 1.73%	44,164 $14.3 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $93,876 - $116,664	400 Added 0.93%	43,414 $12.4 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $820,702 - $1.02 Million	3,650 Added 9.27%	43,014 $11.9 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $798,868 - $983,119	3,605 Added 10.08%	39,364 $9.1 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $189,577 - $245,217	1,050 Added 3.03%	35,759 $8.21 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $665,496 - $861,516	-4,050 Reduced 10.45%	34,709 $6.48 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $117,414 - $155,367	900 Added 2.38%	38,759 $6.54 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $219,330 - $253,695	-1,500 Reduced 3.81%	37,859 $5.6 Million
Q2 2020 Aug 17, 2020	SELL	$136.42 - $164.18 $473,377 - $569,704	-3,470 Reduced 8.1%	39,359 $6.46 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $266,672 - $330,064	2,240 Added 5.52%	42,829 $5.94 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $64,152 - $79,458	-600 Reduced 1.46%	40,589 $5.34 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $40,327 - $47,072	-364 Reduced 0.88%	41,189 $4.56 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $515,031 - $606,229	-4,627 Reduced 10.02%	41,553 $5.39 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $169,440 - $189,824	1,600 Added 3.59%	46,180 $5.34 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $2,575 - $3,219	30 Added 0.07%	44,580 $4.78 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $359,575 - $412,680	4,750 Added 11.93%	44,550 $3.8 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $230,050 - $271,560	3,100 Added 8.45%	39,800 $3.08 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $16,388 - $17,578	200 Added 0.55%	36,700 $3.1 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $2.81 Million - $3.12 Million	36,500	36,500 $3.12 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$76.5 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.2 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.5 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.7 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on New England Asset Management Inc with notifications on news.

Account